{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:35:29Z","timestamp":1787020529980,"version":"build-2736575974"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"AstraZeneca"},{"name":"Vetenskapsr\u00e5det,Sweden","award":["2018-00904"],"award-info":[{"award-number":["2018-00904"]}]},{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-Lungfonden","doi-asserted-by":"publisher","award":["20190403"],"award-info":[{"award-number":["20190403"]}],"id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007051","name":"Uppsala University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007051","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The risk of severe coronavirus disease 2019 (COVID-19) is increased in people with diabetes, but effects of diabetes type and other risk factors remain incompletely characterized. We studied this in a Swedish cohort of hospitalized patients with type 1 and type 2 diabetes (T1D and T2D), also including comparisons with influenza epidemics of recent years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Nationwide healthcare registries were used to identify patients. A total of\u00a011,005 adult patients with diabetes (T1D, n\u2009=\u2009373; T2D, n\u2009=\u200910,632) were hospitalized due to COVID-19 from January 1, 2020 to September 1, 2021. Moreover,\u00a05111 patients with diabetes (304 T1D, 4807 T2D) were hospitalized due to influenza from January 1, 2015 to December 31, 2019. Main outcomes were death within 28\u00a0days after admission\u00a0and new hospitalizations for heart failure (HF), chronic kidney disease (CKD), cardiorenal disease (CRD; composite of HF and CKD), myocardial infarction (MI) and stroke during 1\u00a0year of follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Number of deaths and CRD events were 2025 and 442 with COVID-19 and 259 and 525 with influenza, respectively. Age- and sex-adjusted Cox regression models in COVID-19 showed higher risk of death and HF in T1D vs. T2D, hazard ratio (HR) 1.77 (95% confidence interval 1.41\u20132.22) and 2.57 (1.31\u20135.05). With influenza, T1D was associated with higher risk of death compared with T2D, HR 1.80 (1.26\u20132.57). Older age and previous CRD were associated with higher risks of death and hospitalization for CRD. After adjustment for prior comorbidities, mortality differences were still significant, but there were no significant differences in cardiovascular and renal outcomes. COVID-19 relative to influenza was associated with higher risk of death in both T1D and T2D, HR 2.44 (1.60\u20133.72) and 2.81 (2.59\u20133.06), respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In Sweden, patients with T1D as compared to T2D had a higher age- and sex-adjusted risk of death within 28\u00a0days and HF within one year after COVID-19 hospitalization, whereas the risks of other non-fatal cardiovascular and renal disease events were similar. Patients with T1D as well as T2D have a greater mortality rate when hospitalized due to COVID-19 compared to influenza, underscoring the importance of vaccination and other preventive measures against COVID-19 for diabetes patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12933-022-01719-x","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T10:03:37Z","timestamp":1671098617000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Patients with type 1 and type 2 diabetes hospitalized with COVID-19 in comparison with influenza: mortality and cardiorenal complications assessed by nationwide Swedish registry data"],"prefix":"10.1186","volume":"21","author":[{"given":"Robin","family":"Krist\u00f3fi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Bodegard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viveca","family":"Ritsinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Thuresson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Nathanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Nystr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Norhammar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan W.","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,15]]},"reference":[{"key":"1719_CR1","unstructured":"WHO\/Europe | Coronavirus disease (COVID-19) outbreak - WHO announces COVID-19 outbreak a pandemic [Internet]. https:\/\/www.euro.who.int\/en\/health-topics\/health-emergencies\/coronavirus-covid-19\/news\/news\/2020\/3\/who-announces-covid-19-outbreak-a-pandemic. Accessed 16 Jun 2021."},{"key":"1719_CR2","unstructured":"WHO Coronavirus (COVID-19) Dashboard | WHO coronavirus (COVID-19) dashboard with vaccination data [Internet]. https:\/\/covid19.who.int\/. Accessed 14 Sep 2021."},{"key":"1719_CR3","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1001\/jama.2020.12839","volume":"324","author":"WJ Wiersinga","year":"2020","unstructured":"Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. J Am Med Assoc. 2020;324:782\u201393.","journal-title":"J Am Med Assoc"},{"key":"1719_CR4","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China Lancet. 2020;395:497\u2013506.","journal-title":"China Lancet"},{"key":"1719_CR5","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1080\/00325481.2020.1786964","volume":"132","author":"MS Gold","year":"2020","unstructured":"Gold MS, Sehayek D, Gabrielli S, Zhang X, McCusker C, Ben-Shoshan M. COVID-19 and comorbidities: a systematic review and meta-analysis. Postgrad Med. 2020;132:749\u201355. https:\/\/doi.org\/10.1080\/00325481.2020.1786964.","journal-title":"Postgrad Med"},{"key":"1719_CR6","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000024971","volume":"100","author":"S Cheng","year":"2021","unstructured":"Cheng S, Zhao Y, Wang F, Chen Y, Kaminga AC, Xu H. Comorbidities\u2019 potential impacts on severe and non-severe patients with COVID-19: a systematic review and meta-analysis. Medicine (Baltimore). 2021;100: e24971.","journal-title":"Medicine (Baltimore)"},{"key":"1719_CR7","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ijid.2020.03.017","volume":"94","author":"J Yang","year":"2020","unstructured":"Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities and its effects in coronavirus disease 2019 patients: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91\u20135.","journal-title":"Int J Infect Dis"},{"key":"1719_CR8","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.2337\/dc20-2839","volume":"44","author":"R Kristofi","year":"2021","unstructured":"Kristofi R, Bodegard J, Norhammar A, Thuresson M, Nathanson D, Nystr\u00f6m T, et al. Cardiovascular and renal disease burden in type 1 compared with type 2 diabetes: a two-country nationwide observational study. Diabetes Care. 2021;44:1211\u20138.","journal-title":"Diabetes Care"},{"key":"1719_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2021.100105","volume":"4","author":"A Rawshani","year":"2021","unstructured":"Rawshani A, Kj\u00f6lhede EA, Rawshani A, Sattar N, Eeg-Olofsson K, Adiels M, et al. Severe COVID-19 in people with type 1 and type 2 diabetes in Sweden: a nationwide retrospective cohort study. Lancet Reg Heal Eur. 2021;4: 100105.","journal-title":"Lancet Reg Heal Eur"},{"key":"1719_CR10","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/S2213-8587(20)30405-8","volume":"9","author":"SJ McGurnaghan","year":"2021","unstructured":"McGurnaghan SJ, Weir A, Bishop J, Kennedy S, Blackbourn LAK, McAllister DA, et al. Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland. Lancet Diabetes Endocrinol. 2021;9:82\u201393.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1719_CR11","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/S2213-8587(21)00089-9","volume":"9","author":"M Gao","year":"2021","unstructured":"Gao M, Piernas C, Astbury NM, Hippisley-Cox J, O\u2019Rahilly S, Aveyard P, et al. Associations between body-mass index and COVID-19 severity in 6\u00b79 million people in England: a prospective, community-based, cohort study. Lancet Diabetes Endocrinol. 2021;9:350\u20139. https:\/\/doi.org\/10.1016\/S2213-8587(21)00089-9.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1719_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/bmjnph-2021-000375","author":"W Sawadogo","year":"2022","unstructured":"Sawadogo W, Tsegaye M, Gizaw A, Adera T. Overweight and obesity as risk factors for COVID-19-associated hospitalisations and death: systematic review and meta-analysis. BMJ Nutr Prev Heal. 2022. https:\/\/doi.org\/10.1136\/bmjnph-2021-000375.","journal-title":"BMJ Nutr Prev Heal."},{"key":"1719_CR13","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1007\/s00125-021-05458-8","volume":"64","author":"S Schlesinger","year":"2021","unstructured":"Schlesinger S, Neuenschwander M, Lang A, Pafili K, Kuss O, Herder C, et al. Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis. Diabetologia. 2021;64:1480\u201391.","journal-title":"Diabetologia"},{"key":"1719_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0241824","volume":"15","author":"FK Ho","year":"2020","unstructured":"Ho FK, Petermann-Rocha F, Gray SR, Jani BD, VittalKatikireddi S, Niedzwiedz CL, et al. Is older age associated with COVID-19 mortality in the absence of other risk factors? General population cohort study of 470,034 participants. PLoS ONE. 2020;15:1\u201311. https:\/\/doi.org\/10.1371\/journal.pone.0241824.","journal-title":"PLoS ONE"},{"key":"1719_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-19741-6","volume":"11","author":"H Peckham","year":"2020","unstructured":"Peckham H, de Gruijter NM, Raine C, Radziszewska A, Ciurtin C, Wedderburn LR, et al. Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nat Commun. 2020;11:1\u201310. https:\/\/doi.org\/10.1038\/s41467-020-19741-6.","journal-title":"Nat Commun"},{"key":"1719_CR16","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1093\/eurheartj\/suaa064","volume":"22","author":"F Muscente","year":"2020","unstructured":"Muscente F, De CR, Cuore D, Cardiologia C, Pisana CAO, Cisanello O, et al. Causal relationship between influenza infection and risk of acute myocardial infarction\u202f: pathophysiological hypothesis and clinical implications. Eur Hear J Suppl. 2020;22:68\u201372.","journal-title":"Eur Hear J Suppl"},{"key":"1719_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2021.100054","author":"K Str\u00e5lin","year":"2021","unstructured":"Str\u00e5lin K, Wahlstr\u00f6m E, Walther S, Bennet-Bark AM, Heurgren M, Lind\u00e9n T, et al. Mortality trends among hospitalised COVID-19 patients in Sweden: a nationwide observational cohort study. Lancet Reg Heal Eur. 2021. https:\/\/doi.org\/10.1016\/j.lanepe.2021.100054.","journal-title":"Lancet Reg Heal Eur."},{"key":"1719_CR18","unstructured":"V\u00e5rd och covid-19 - Socialstyrelsen [Internet]. https:\/\/www.socialstyrelsen.se\/statistik-och-data\/statistik\/statistik-om-covid-19\/statistik-om-slutenvard-av-patienter-med-covid-19\/. Accessed 19 Feb 2022."},{"key":"1719_CR19","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s10654-021-00732-w","volume":"36","author":"J Bergman","year":"2021","unstructured":"Bergman J, Ballin M, Nordstr\u00f6m A, Nordstr\u00f6m P. Risk factors for COVID-19 diagnosis, hospitalization, and subsequent all-cause mortality in Sweden: a nationwide study. Eur J Epidemiol. 2021;36:287\u201398. https:\/\/doi.org\/10.1007\/s10654-021-00732-w.","journal-title":"Eur J Epidemiol"},{"key":"1719_CR20","unstructured":"Statistik om covid-19 och coronapandemin - Socialstyrelsen [Internet]. https:\/\/www.socialstyrelsen.se\/statistik-och-data\/statistik\/statistik-om-covid-19\/. Accessed 24 Jul 2022."},{"key":"1719_CR21","unstructured":"Sveriges befolkningspyramid [Internet]. https:\/\/www.scb.se\/hitta-statistik\/sverige-i-siffror\/manniskorna-i-sverige\/sveriges-befolkningspyramid\/. Accessed 24 Jul 2022."},{"key":"1719_CR22","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S2213-2600(20)30527-0","volume":"9","author":"L Piroth","year":"2021","unstructured":"Piroth L, Cottenet J, Mariet AS, Bonniaud P, Blot M, Tubert-Bitter P, et al. Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study. Lancet Respir Med. 2021;9:251\u20139. https:\/\/doi.org\/10.1016\/S2213-2600(20)30527-0.","journal-title":"Lancet Respir Med"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-022-01719-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-022-01719-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-022-01719-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T10:09:49Z","timestamp":1671098989000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-022-01719-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,15]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1719"],"URL":"https:\/\/doi.org\/10.1186\/s12933-022-01719-x","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,15]]},"assertion":[{"value":"25 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Stockholm Regional Ethics Committee (reference numbers 2020\u201302917 and 2013\/2206\u201331).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AstraZeneca was the sponsor of this study. J.B. is a full-time employee of AstraZeneca. J.W.E. has received reimbursement for consultancies or research support from Novo Nordisk, Merck Sharp & Dohme, Boehringer Ingelheim, Ilya Pharma and AstraZeneca. A.N. has received honoraria from MSD, AstraZeneca, Eli Lilly, Boehringer Ingelheim, and Novo Nordisk. M.T. is employed by an independent statistical consultant company, Statisticon AB, of which AstraZeneca Nordic-Baltic is a client. D.N. has received consultancy fees from Novo Nordisk, AstraZeneca, and Eli Lilly. T.N. has received unrestricted grants from AstraZeneca and Novo Nordisk and has served on national advisory boards of Novo Nordisk, Sanofi-Aventis, Eli Lilly, MSD and Boehringer Ingelheim. V.R. has received honoraria from AstraZeneca, Novo Nordisk, and Boehringer Ingelheim on expert group participation. No other potential conflicts of interest relevant to this article were reported.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"282"}}